Companies / Regenerx Biopharmaceuticals Inc
Regenerx Biopharmaceuticals Inc
RGRXCIK 707511
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 30, 2021 | Cavazza Paolo 10% owner | Buy Open-market buy | Common Stock | $300.0K | +1.5M | 1,500,000 | medium |
| Jun 30, 2021 | Goldstein Allan L Director | Buy Open-market buy | Common Stock | $25.0K | +125K +8.26% | 1,637,793 | low |
| Jun 30, 2021 | Finkelstein J J CEO | Buy Open-market buy | Common Stock | $15.0K | +75K +4.58% | 1,712,991 | low |
| Feb 13, 2020 | Goldstein Allan L Director | Gift | Common Stock | $0 | -200K -11.68% | 1,512,793 | low |
| Dec 8, 2021 | Goldstein Allan L Director | Gift | Common Stock | $0 | -130K -7.94% | 1,507,793 | low |
| Feb 11, 2015 | Goldstein Allan L Director | Grant Grant or award | Stock Option (right to buy) | — | +100K | 100,000 | low |
| Feb 11, 2015 | Bove Mauro Director | Grant Grant or award | Stock Option (right to buy) | — | +100K | 100,000 | low |
| Feb 11, 2015 | Elsey R Don Director | Grant Grant or award | Stock Option (right to buy) | — | +100K | 100,000 | low |